AIMD
Ainos, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.61
+3.21%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.7x
Market Cap
$11.89M
MomentumView details →
1D Return
+3.21%
YTD Return
−4.27%
RSI (14)
57.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.7x
Market Cap
$11.89M
RSI (14)
57.3
MomentumView details →
1D Return
+3.21%
YTD Return
−4.27%
SummaryUpdated Jun 1, 2026
Ainos, Inc. (NASDAQ:AIMD) is a biotechnology company founded in 1984 and headquartered in San Diego, California. Originally incorporated as Amarillo Biosciences, Inc., the company rebranded to Ainos in May 2021 and went public through an IPO in January 2021. The company operates in the healthcare sector, focusing on developing medical technologies for point-of-care diagnostic testing and novel therapeutic treatments for various disease indications.
Similar companies
Latest newsMore news →
Ainos, Inc. announced the global launch of its Atmosphere Engine platform, which generates high-purity nitrogen and oxygen on-site for active environmental management in semiconductor manufacturing.16d agoAinos, Inc. announced the launch of its second-generation AI Nose platform, featuring upgrades in software, firmware, edge computing, and hardware for continuous real-world deployment.18d agoAinos, Inc. announced its financial results for the second quarter ended June 30, 2026, and provided a business update on its AI Nose technology across semiconductor manufacturing, industrial infrastructure, robotics, and healthcare markets.32d ago